Key result
Recombinant BmP05 acts as a selective antagonist against SKCa channels with an IC50 of 0.92 microM, with specific N-terminal and C-terminal residues essential for its interaction and specificity.
Effect estimate: IC50 0.92 microM
The study identifies key structural elements of the scorpion toxin BmP05, specifically the N-terminal alpha-helix and basic residues, that are essential for its interaction with SKCa channels.
Guides SKCa-selective peptide engineering; leaves open translation to human cardiovascular models.
Four peptide inhibitors of small-conductance Ca(2+)-activated, apamin-sensitive K(+) channels (SK(Ca)) have been isolated from the venom of the Chinese scorpion Buthus martensi, named BmP01, BmP02, BmP03, and BmP05, respectively [Romi-Lebrun, R. (1997) Eur. J. Biochem. 245, 457-464]. Among them BmP05 with 31 amino acid residues has been intensively studied due to its most potent toxicity. To investigate the structure-function relationship of BmP05, its wild type and seven mutants (their C-termini unamidated) were successfully expressed in the yeast secretion system and purified with a high yield over 8 mg/L. Their toxicity to mice and electrophysiological activity on the K(+) currents (SK(Ca) and Kv) in rat adrenal chromaffin cells were measured and compared. The results indicated the following: (1) As a selective antagonist against SK(Ca), 1 microM rBmP05 is equivalent to 0.2 microM apamin, and its IC(50) is 0.92 microM. (2) The basic residues Lys and Arg located at positions 6 and 13 in the N-terminal alpha-helix region are essential and synergetic in the interaction of the toxin with SK(Ca). (3) Disruption of the alpha-helix by mutation of Gln at position 9 with Pro results in almost total loss of toxicity. (4) The C-terminal residue His31 plays an auxiliary role in the interaction of the toxin with SK(Ca). (5) The beta-turn connecting two beta-sheets near the C-terminal part is responsible for the specificity of the toxin to the different subtypes of K(+) channels.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2002) studied this question. rBmP05 (wild type and mutants) vs. apamin was evaluated on Electrophysiological activity on K(+) currents (SKCa and Kv) and toxicity (IC50 0.92 microM). Recombinant BmP05 acts as a selective antagonist against SKCa channels with an IC50 of 0.92 microM, with specific N-terminal and C-terminal residues essential for its interaction and specificity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: